Nanogami

Nanogami is a biotechnology company based in Leipzig, Germany, founded in 2022. As a subsidiary of Germany’s Federal Agency for Disruptive Innovation (SPRIND), it was established through a collaboration with tilibit GmbH. The company specializes in DNA origami technology, which allows for precise molecular placement at the nanoscale to create advanced biochips. Nanogami's proprietary DNA origami platform enables the design of nanoscale machines and biochips that can manipulate individual molecules with high precision. These biochips are characterized by ultra-high density and modularity, making them suitable for applications in research, diagnostics, and personalized medicine. The company focuses on enhancing sequencing, transcriptomics, and proteomics through its technology, and it aims to develop multi-layered nanomachines for pollutant monitoring and targeted drug delivery. With a vision to integrate nanomachines with digital chips, Nanogami is targeting sectors such as life sciences, diagnostics, and quantum computing. The company is committed to expanding its technology and increasing the functional complexity of its biochips.

Research Munich, Germany ~29 employees

Work at Nanogami in HR or recruiting? Claim this page

Employees
29
0% in the 3 months to Sep 2026
12-month attrition
360%
H1B sponsor
NA

Headcount trend

Nanogami went from 1 employees in Oct 2024 to 0 in Sep 2026.

Peer reviews

Worked with someone at Nanogami?

Anonymous peer reviews on OffTheRecord

Read or write a review

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.